Silver Book Fact

Studies of patients with myocardial infarction found that warfarin reduced stroke risk compared to placebo
by 40% to 55%.

ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group. Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction. Lancet. 1994; 343(8896): 499-503. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2894%2991458-3/abstract

Reference

Title
Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction
Publication
Lancet
Publication Date
1994
Authors
ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group
Volume & Issue
Volume 343, Issue 8896
Pages
499-503
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…  
  • DR Treatment Savings in the US
    Every year, the U.S. saves an estimated $1.6 billion by treating DR.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Lucentis to treat wet age-related macular degeneration (AMD)
    An FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)–ranibizumab (Lucentis)–maintained vision in 95% of clinical trial participants and improved vision by 15 or more letters in approximately 25%…